All the 18 newly identified metabolites were significantly negatively correlated with TC, LDL-C, and Apo-B levels in PCa patients, whereas only a few metabolites were negatively correlated with HDL-C and Apo-A levels. The gene discussed is APOA1; the disease is posterior cortical atrophy.